-
BioMarin acquires LEAD Therapeutics
February 5th, 2010NOVATO — BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) said it plans to acquire LEAD Therapeutics Inc. of San Bruno in a stock deal worth $18 million up front and up to $97 million as the drug is submitted for government review and later released.
Lists Online
-
-
-
Latest articles
-
-
-
NBBJ Insider Blog- June jobs picture remains bleak June 30, 2010
- A warning on financial reform and community banks June 29, 2010
- Mortgage fraud and the financial crisis June 25, 2010
-
Previous articles
News archive search
-
Business Journal connections
Mobile